[{"data":1,"prerenderedAt":186},["ShallowReactive",2],{"drug-perampanel":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":20,"regimens":75,"contraindications":102,"warnings":103,"renal":111,"monitoring":112,"interactions":113,"review":114,"examples":117,"atc":123,"iran":125,"usApproval":132,"links":138,"populations":152},"perampanel",1,{"fa":7,"en":8},"پرامپانل","Perampanel","nervous-system",{"fa":11,"en":12},"آنتاگونیست گیرنده AMPA (ضدصرع)","AMPA receptor antagonist (antiepileptic)",[14],{"name":15,"market":16},"Fycompa","US",[18,19,7],"fycompa","فایکومپا",[21,35,43,51,59,67],{"id":22,"form":23,"route":24,"label":25,"concentration":26,"markets":30,"refs":31},"tab-2","tablet","oral","2 mg tablet",{"amount":27,"unit":28,"perUnit":23,"scored":29},2,"mg",false,[16],[32],{"source":33,"section":34},"fda-fycompa","3",{"id":36,"form":23,"route":24,"label":37,"concentration":38,"markets":40,"refs":41},"tab-4","4 mg tablet",{"amount":39,"unit":28,"perUnit":23,"scored":29},4,[16],[42],{"source":33,"section":34},{"id":44,"form":23,"route":24,"label":45,"concentration":46,"markets":48,"refs":49},"tab-6","6 mg tablet",{"amount":47,"unit":28,"perUnit":23,"scored":29},6,[16],[50],{"source":33,"section":34},{"id":52,"form":23,"route":24,"label":53,"concentration":54,"markets":56,"refs":57},"tab-8","8 mg tablet",{"amount":55,"unit":28,"perUnit":23,"scored":29},8,[16],[58],{"source":33,"section":34},{"id":60,"form":23,"route":24,"label":61,"concentration":62,"markets":64,"refs":65},"tab-10","10 mg tablet",{"amount":63,"unit":28,"perUnit":23,"scored":29},10,[16],[66],{"source":33,"section":34},{"id":68,"form":23,"route":24,"label":69,"concentration":70,"markets":72,"refs":73},"tab-12","12 mg tablet",{"amount":71,"unit":28,"perUnit":23,"scored":29},12,[16],[74],{"source":33,"section":34},[76],{"id":77,"disease":78,"label":79,"population":82,"type":85,"unit":28,"dose":86,"refs":89,"notes":92},"pos","epilepsy",{"fa":80,"en":81},"تشنج پارشیل (۴ سال به بالا) — ۲ mg هنگام خواب، هر هفته ۲ mg بیشتر؛ نگهدارنده ۸ تا ۱۲ mg","Partial-onset seizures (≥4 y) — 2 mg at bedtime, +2 mg weekly; maintenance 8–12 mg",{"minAge":83},{"value":39,"unit":84},"year","titration",{"dividedDoses":5,"titration":87},{"start":27,"increment":27,"incrementEveryDays":88,"targetMin":55,"targetMax":71,"max":71},7,[90],{"source":33,"section":91},"2.1",[93],{"text":94,"refs":97},{"fa":95,"en":96},"با القاگر متوسط\u002Fقوی CYP3A4 (کاربامازپین، فنی‌توئین، اکس‌کاربازپین) شروع ۴ mg. تشنج تونیک-کلونیک ژنرالیزه (۱۲ سال به بالا): نگهدارنده ۸ mg.","With moderate\u002Fstrong CYP3A4 inducers (carbamazepine, phenytoin, oxcarbazepine) start at 4 mg. Primary generalised tonic-clonic (≥12 y): maintenance 8 mg.",[98,100],{"source":33,"section":99},"2",{"source":33,"section":101},"2.2",[],[104],{"text":105,"refs":108},{"fa":106,"en":107},"هشدار جعبه‌ای: واکنش‌های روانی و رفتاری جدی (پرخاشگری، خصومت، افکار قتل).","Boxed warning: serious psychiatric and behavioural reactions (aggression, hostility, homicidal ideation).",[109],{"source":33,"section":110},"Boxed Warning",[],[],[],{"status":115,"reviewer":116,"date":116},"unverified",null,[118],{"regimen":77,"formulation":22,"input":119,"expect":122},{"ageYears":120,"weightKg":121},30,70,{"perDose":27,"tabletsPerDoseRounded":5},[124],"N03AX22",{"status":126,"refs":127},"not-found",[128],{"source":129,"section":130,"url":131},"darooyab-generic","search","https:\u002F\u002Fwww.darooyab.ir\u002FSearch?q=Perampanel",{"kind":133,"refs":134,"id":137},"NDA",[135],{"source":33,"section":136},"SPL approval \u002F marketing category","NDA202834",[139,142,146,149],{"kind":140,"url":141,"label":137},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=202834",{"kind":143,"url":144,"label":145},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=71cf3309-e182-473c-8b0b-280cabd0e122","FDA Fycompa",{"kind":147,"url":148,"label":8},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa614006.html",{"kind":150,"url":151,"label":124},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=N03AX22",{"pregnancy":153,"pediatric":162,"geriatric":170,"reproductive":178},{"level":154,"text":155,"quote":158,"refs":159},"caution",{"fa":156,"en":157},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Risk Summary There are no adequate data on the developmental risk associated with use in pregnant women.",[160],{"source":33,"section":161},"8.1",{"level":154,"text":163,"quote":166,"refs":167},{"fa":164,"en":165},"برچسب برای کودکان شرط، محدودیت سنی یا نکته دارد؛ جمله برچسب در زیر آمده است.","The label has conditions, age limits or notes for children; the label sentence is quoted below.","Safety and effectiveness of FYCOMPA for the treatment of partial-onset seizures have been established in pediatric patients 4 years of age and older.",[168],{"source":33,"section":169},"8.4",{"level":154,"text":171,"quote":174,"refs":175},{"fa":172,"en":173},"برچسب: در سالمندان با احتیاط و معمولاً از دوز پایین شروع شود.","Label: use with caution in older adults, usually starting at the low end of the dose range.","Clinical studies of FYCOMPA did not include sufficient numbers of patients aged 65 and over to determine the safety and efficacy of FYCOMPA in the elderly population.",[176],{"source":33,"section":177},"8.5",{"level":154,"text":179,"quote":182,"refs":183},{"fa":180,"en":181},"برچسب نکته‌ای درباره بارداری، پیشگیری یا باروری زنان و مردان دارد.","Label has advice on pregnancy testing, contraception or fertility for females and males.","Contraception Use of FYCOMPA may reduce the efficacy of hormonal contraceptives containing levonorgestrel.",[184],{"source":33,"section":185},"8.3",1792156191117]